Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

258.66
-6.0800-2.30%
Post-market: 259.250.5900+0.23%19:59 EDT
Volume:8.29M
Turnover:2.16B
Market Cap:623.19B
PE:29.95
High:263.98
Open:263.68
Low:258.33
Close:264.74
52wk High:281.07
52wk Low:182.94
Shares:2.41B
Float Shares:2.40B
Volume Ratio:1.40
T/O Rate:0.34%
Dividend:5.24
Dividend Rate:2.03%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:25.74%
ROA:8.59%
PB:7.33
PE(LYR):23.44

Loading ...

Dow Jones Top Company Headlines at 1 am ET: Biggest AI Rivals Agree They Need to Slow it Down | Amazon ...

Dow Jones
·
Sep 14

J&J - Rybrevant Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Nsclc

THOMSON REUTERS
·
Sep 14

Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations with 21 Air After Miami Crash | Pfizer ...

Dow Jones
·
Sep 14

Johnson & Johnson in Advanced Talks to Sell Orthopaedics Unit to Apollo in Potential $20B Deal

Deep News
·
Sep 13

Apollo in Advanced Talks to Acquire Johnson \u0026 Johnson's Orthopedics Unit in Deal Valued Near $20B

Stock News
·
Sep 12

J&J Orthopedics Unit Draws Apollo Interest in Potential $20 Billion Deal, Bloomberg News Reports

Reuters
·
Sep 12

Apollo Global is Said in Talks to Acquire J&J’s Orthopedics Unit - Bloomberg News

THOMSON REUTERS
·
Sep 12

DBS Sticks to Their Hold Rating for Johnson & Johnson (JNJ)

TIPRANKS
·
Sep 12

Tylenol Maker, Pharmacy Chains Urge US Appeals Court to Revisit Decision over Alleged Autism Link

Reuters
·
Sep 12

RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

TIPRANKS
·
Sep 11

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout

Reuters
·
Sep 10

Johnson & Johnson Announces R$ 0.3 Per Unit Dividend for 3Q 2026

Reuters
·
Sep 10

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

TIPRANKS
·
Sep 10

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS
·
Sep 10

2 Reasons Cooper Companies Stock is by Far the Worst in the S&P 500 Today

Dow Jones
·
Sep 10

Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup

Dow Jones
·
Sep 10

Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress

Dow Jones
·
Sep 09

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Reuters
·
Sep 09